C. Rhudy

Impact of a subcutaneous casirivimab and imdevimab clinic in outpatients with symptomatic COVID-19: A single-center, propensity-matched cohort study

Justin J. Thomas, C. Rhudy, Samantha H Bochenek, 2022, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

Efficacy and safety of vancomycin loading doses in critically ill patients with methicillin-resistant Staphylococcus aureus infection

A. Flannery, P. Morris, D. Burgess, 2021, Therapeutic advances in infectious disease.

Inflammatory Bowel Disease in Appalachian Kentucky: An Investigation of Outcomes and Health Care Utilization.

J. Talbert, T. Barrett, Deborah R. Flomenhoft, 2023, Inflammatory bowel diseases.

Chronic opioid use is associated with early biologic discontinuation in inflammatory bowel disease

M. Singleton, J. Talbert, Courtney Perry, 2021, Alimentary pharmacology & therapeutics.

Rural/Urban Disparities in Utilization of Diabetes Self-Management Training to the Fee-for-Service Medicare Population

J. Talbert, A. Schadler, Christian Rhudy, 2020 .

Impact of the COVID-19 pandemic on hepatitis C outcomes at a health-system specialty pharmacy.

A. Schadler, D. Damico, C. Rhudy, 2022, Journal of Managed Care & Specialty Pharmacy.